U.S. Securities and Exchange Commission
Washington, D.C. 20549
Form 10-QSB
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the quarter ended: June 30, 2000
Commission file no. 0-24921
Surgical Safety Products, Inc.
--------------------------------------------
(Name of small business issuer in its charter)
New York 65-0565144
------------------------------- -------------------
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
2018 Oak Terrace
Sarasota, Florida 34231
--------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
Issuer's telephone number (941) 927-7874
Securities registered under Section 12(b) of the Exchange Act:
Name of each exchange on
Title of each class which registered
None
----------------------------- -------------------------
Securities registered under Section 12(g) of the Exchange Act:
Common Stock, $.001 par value
-----------------------------------
(Title of class)
Copies of Communications Sent to:
Mercedes Travis, Esq.
Mintmire & Associates
265 Sunrise Avenue, Suite 204
Palm Beach, FL 33480
Tel: (561) 832-5696; Fax: (561) 659-5371
<PAGE>
Indicate by Check whether the issuer (1) filed all reports required to
be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months
(or for such shorter period that the registrant was required to file such
reports), and (2) has been subject to such filing requirements for the past 90
days.
Yes X No
--- ---
As of June 30, 2000, there are 14,515,373 shares of voting stock of the
registrant issued and outstanding.
<PAGE>
PART I
Item 1. Financial Statements
Condensed Balance Sheets F-1
Condensed Statements of Operations F-3
Condensed Statements of Cash Flows F-4
Notes to the Financial Statements F-6
-1-
<PAGE>
<TABLE>
<CAPTION>
SURGICAL SAFETY PRODUCTS, INC
CONDENSED BALANCE SHEETS
(Unaudited) (Audited)
June 30, December 31,
2000 1999
<S> <C> <C>
Assets
Current Assets
Cash $ 231,372 $ 516,799
Trade receivables 14,133 17,086
Prepaid expenses and deposits 66,855 118,569
------------------ ------------------------
Total current assets 312,360 652,454
------------------ ------------------------
Property and equipment, net 189,490 203,533
------------------ ------------------------
Other Assets
Intangible assets, net 506,088 270,487
Software development costs, net 235,040 139,382
Other assets 10,250 10,250
------------------ ------------------------
Total other assets 751,378 420,119
------------------ ------------------------
Total Assets $ 1,253,228 $ 1,276,106
================== ========================
</TABLE>
F-1
<PAGE>
<TABLE>
<CAPTION>
SURGICAL SAFETY PRODUCTS, INC
CONDENSED BALANCE SHEETS
(Unaudited) (Audited)
June 30, December 31,
2000 1999
<S> <C> <C>
Liabilities and Stockholders' Equity
Current Liabilities
Line of Credit $ 100,000 $ 100,000
Notes Payable - related parties 37,500 52,500
Accounts payable and accrued expenses 199,136 438,057
Total current liabilities 336,636 590,557
Long-Term Liabilities
Notes payable 1,110,905 650,000
Total Liabilities 1,447,541 1,240,557
Stockholders' Deficit
Common stock, $.001 par value,
20,000,000 shares authorized;
14,515,373shares issued
and outstanding in 2000 and 1999
respectively 14,516 14,516
Common stock held in escrow (2,187) (2,700)
Additional paid-in capital 3,433,476 2,804,020
Accumulated deficit (3,640,118) (2,780,287)
Total stockholders' deficit (194,313) 35,549
Total Liabilities and Stockholders' Equity $ 1,253,228 $ 1,276,106
</TABLE>
The accompanying notes are an integral
part of these financial statements.
F-2
<PAGE>
<TABLE>
<CAPTION>
SURGICAL SAFETY PRODUCTS, INC
CONDENSED STATEMENT OF OPERATIONS
THREE AND SIX MONTHS ENDED JUNE 30, 2000 AND 1999
(UNAUDITED)
Six Months Ending Three Months Ending
June 30, June 30,
2000 1999 2000 1999
<S> <C> <C> <C> <C>
Revenue $ 159,725 $ 52,734 24,069 $ 13,157
Costs and expenses
Cost of revenues 23,372 8,135 7,339 7,874
Operating expenses 751,306 396,900 415,588 257,916
Research and development 33,181 20,085 18,837 13,418
expenses
Interest expense 211,697 7,440 30,276 5,919
Total costs 1,019,556 432,560 472,040 285,127
Net loss before income taxes (859,831) (379,826) (447,971) (271,970)
Provision for income
taxes
Net loss $ (859,831) $ (379,826) (447,971) $ (271,970)
Net loss per share $ (0.072) $ (0.040) (0.037) $ (0.020)
</TABLE>
The accompanying notes are an integral
part of these financial statements.
F-3
<PAGE>
<TABLE>
<CAPTION>
SURGICAL SAFETY PRODUCTS, INC.
CONDENSED STATEMENTS OF CASH FLOWS
SIX MONTHS ENDED JUNE 30, 2000 AND 1999
(UNAUDITED)
<S> <C> <C>
2000 1999
Cash Flows From Operating Activities
Net loss $ (859,831) $ (379,826)
Adjustments to reconcile net loss to cash
used in operating activities
Depreciation and amortization 125,698 58,013
Common stock and options issued for services and
employee compensation - 41,303
Stock option compensation expense 4,682 (91,113)
Accrued interest added to notes payable 37,663
Interest expense - convertible debt 167,143
Decrease (increase) in operating assets
Receivables (2,953) (8,040)
Inventory - 436
Prepaids and others 51,715
Increase (decrease) in operating liabilities
Accounts payable and accrued expenses (238,920) 14,498
Total adjustments (149,066) 15,097
Net cash used in operating activities (708,897) (364,729)
Cash Flows From Investing Activities
Furniture and equipment purchased (21,549) (92,039)
Software development additions (119,981) (48,923)
Net cash used in investing activities (141,530) (140,962)
Cash Flows From Financing Activities
Proceeds/(repayments) -related party loans (15,000) 77,500
Advances/(repayments) on line of credit, net - 100,000
Loan costs (70,000)
Proceeds from notes payable 650,000
Proceeds from issuance of common stock - 475,000
Net cash provided by financing activities 565,000 652,500
Net increase (decrease) in cash (285,427) 146,809
Cash at beginning of year 516,799 41,191
Cash at end of year $ 231,372 $ 188,000
</TABLE>
The accompanying notes are an integral
part of these financial statements.
F-4
<PAGE>
SURGICAL SAFETY PRODUCTS, INC.
CONDENSED STATEMENTS OF CASH FLOWS
SIX MONTHS ENDED JUNE 30, 2000 AND 1999
(UNAUDITED)
2000 1999
Supplemental Cash Flow Information:
Cash paid for interest $ 5,783 $ 4,647
For purposes of the statement of cash flows, management considers all deposits
and financial instruments with original maturities of less than three months to
be cash and cash equivalents.
Material non-cash transactions not reflected in the statement of cash flows
include:
For the Six Months Ended June 30, 2000
- Deferred financing costs of $231,385 related to the issuance of warrants in
conjunction with the issuance of notes payable in March 2000 - Common stock and
additional paid in capital of $226,759 issued for conversion of notes payable
For the Six Months Ended June 30, 1999
- The Company received fixed assets in the amount of $58,700 for which it had
recorded deposits of such amount at December 31, 1998
The accompanying notes are an integral
part of these financial statements.
F-5
<PAGE>
Note 1 - Accounting Policies
Basis of Presentation
The condensed financial statements of Surgical Safety Products, Inc. (Company)
have been prepared without audit, pursuant to the rules and regulations of the
Securities and Exchange Commission. Certain information and footnote disclosures
normally included in financial statements prepared in accordance with generally
accepted accounting principles have been condensed or omitted pursuant to such
rules and regulations. These consolidated financial statements should be read in
conjunction with the financial statements and notes thereto included in the
Company's Annual Report on Form 10-KSB for the year ended December 31, 1999.
The results of operations for the six month period ended June 30, 2000 are not
necessarily indicative of the results to be expected for any other period or for
the full year.
In the opinion of Company's management, the accompanying unaudited financial
statements contain all adjustments, consisting of only normally recurring
adjustments, necessary to present fairly the financial positions of June 30,
2000, the results of operations and cash flows for the six months ended June 30,
2000 and June 30, 1999.
Net Loss Per Share
Net loss per share has been computed in accordance with Statement of Financial
Accounting Standards (FASB) No. 128, "Earnings Per Share," by dividing net loss
by the weighted average number of shares outstanding during the period. Common
stock equivalents have not been included in the computation of weighted average
number of shares outstanding since the effect would have been anti-dilutive.
Reclassifications
Certain reclassifications have been made in the prior year's financial
statements to conform to the current period presentation.
Note 2 - Stock Compensation Expense
During fiscal year 1998, the Company issued stock options with an exercise price
that was below market price to certain of its employees. Accordingly, the
Company recorded $91,113 of compensation expense related to the issuance for the
year ended December 31, 1998.
In the first quarter of 1999, the Company canceled these stock options and
issued options with an exercise price above that of market. Accordingly, the
Company decreased its payroll expense by $91,113 for the cancellation of these
options for the quarter ended March 31, 1999.
F-6
<PAGE>
Note 3 -Conversions of Debt
During the six months ended June 30, 2000, the investment banking firm that
holds the notes payable related to the convertible line of credit, elected to
convert $226,759 of principal and interest outstanding into 513,462 shares of
common stock at prices ranging from $0.375 to $0.5625 per shares. These shares
were released from the shares held in escrow by the firm.
On July 11, 2000, the firm converted another $41,683 of principal and interest
into 111,155 shares of common stock at a price of $0.375 per share.
F-7
<PAGE>
Item 2. Management's Discussion and Analysis of Results of Operations.
General
The Company's (OTC BB: SURG) overall mission is the research,
development, production and distribution of innovative products and services for
healthcare. Consisting of both traditional products and innovative
business-to-business e-solutions, the common goal is a safer and more efficient
environment for healthcare workers, manufacturers and patients. Originally
formed as a medical device company, Surgical shifted focus to being an e-company
when the Company's management recognized an untapped market niche: responding to
the critical need for immediate communication and access to information in
healthcare.
Now, the Company operates two divisions providing products and services
to the medical industry. The Information Systems Division, , formerly referred
to as Oasis@work, through its Oasis Information Exchange product line provides
business-to-business on-demand safety and efficiency driven e-business and
information for healthcare workers. The Medical Products and Services Division
develops, manufactures and distributes medical devices.
About Oasis Information Exchange
The Oasis Information Exchange strategy is healthcare e-business
content aggregation and applications integration through a virtual private
network. It links the entire healthcare continuum, which includes healthcare
workers, administration, patients, and healthcare and pharmaceutical
manufacturers. Oasis Information Exchange is a true healthcare data center with
multiple access points. It is an Internet-based virtual private network
consisting of points-of-access via intranets, the Internet, internet appliances,
and through TouchPorts located throughout healthcare facilities across the
country. Although the Company is now focusing on providing its services through
the Internet, TouchPorts remain available as an alternative and are
user-friendly touch-access internet appliances which allow healthcare
professionals access to high quality clinical reference and agency mandated
information services.
During the second quarter of 2000, the Company realized that they were
focusing too much attention to the installation of hardware rather than focusing
its attention on its real product - information. In July 2000, the Company
signed an agreement with the Association of periOperative Registered Nurses
("AORN"), one of the largest nursing organizations in the United States, to
license their content - AORN Journal Online, OR Product Directory, Standards,
Recommended Practices and Guidelines (SRPG) and other content. See "Corporate
Developments".
AORN has 43,000 members and other mailing lists comprising of an
additional 100,000 people. As part of this initiative, the Company will be
producing a CD-ROM that will be mailed to approximately 150,000 people. This
CD-ROM will feature OASiS. The CD will be mailed in the AORN Journsal for
members and as a separate mailing to others.
Due to the increase and availability of PC's and Internet accessibility
in the heathcare environment, the Company realizes that, while in some cases its
OASiS network is needed in a particular environment, by an large, its larger
market is for its content. Essentially the Company is
-2-
<PAGE>
changing from a hardware network supplier to an information broker which will
create an information exchange network for a defined healthcare community that
links the end-users to the industry while adding value to both parties. This is
essentially what the Company was doing all along; however, it had focused on the
delivery system for its product rather than the product itself.
Under the AORN arrangement, the Company's product will be delivered
through the Internet via its website which will be called OasisOR.com. The data
center will have the same type of content from device manufacturers, clinical
associations and other relevant resources; however it will be for OR employees
only, with the information relevant to them.
Although the Company pays AORN a licensing fee, the Company expects to
generate revenue from sponsorships of the CD and from user fees and advertising
on its website. The Company is negotiating its first sponsorship agreement with
US Surgical in lieu of the previous agreement which required massive
expenditures for hardware installations.
The Company plans to scale the concept for other niche markets by
creating websites that cater to a particular speciality. The Company will focus
on providing website and intranet development.
Corporate Developments
The Company entered into an agreement with IBM Global Services
effective January 3, 2000 which included an IBM Customer Agreement and a
Statement of Work (the "IBM Global Agreement"). Under the terms of the IBM
Global Agreement IBM agreed to provide complete implementation and support
service solutions for 1,200 OASiS terminals in an estimated 400 end user
locations during the 12 month period commencing December 1, 1999. On February 3,
2000, IBM Global Services and the Company finalized the Statement of Work. The
services to be provided under the agreement included project planning, site
surveys, product acquisition, network design, web-site hosting services,
premises wiring, OASiS TouchPort Implementation, help desk support and
consulting services. The estimated cost for performing the work was
approximately $10 million. In addition, IBM Global Services agreed to bill the
Company a monthly service charge for pre and post installation support services,
including 24-7 support, and for labor, travel and out of pocket expenses. The
Company was to provide technical resources and oversee the IBM Global's
activities. Due to the new Internet focus the Company has chosen to pursue for
the delivery of its product, there is no longer any need for the services to be
provided by IBM. Effective July 14, 2000, this contract was terminated. Amounts
owed to IBM are being reconciled.
In February 2000, the Company executed an Investment Banking Services
Agreement with Dunwoody Brokerage Services Inc. d/b/a Swartz Institutional
Finance ("Swartz"). Under the agreement, Swartz agreed to introduce entities to
the Company for potential strategic partnerships, licensing arrangements,
mergers, acquisitions, investments or funding. For such services, Swartz was to
receive a scaled fee based upon the value of any completed transaction. Said fee
was payable in cash or stock at Swartz's option and by the issuance of warrants,
the number of which were to be based upon the fee divided by the market price of
the Company's Common Stock. There was no obligation on the part of the Company
to accept any transaction offered by the Swartz to the Company. Since no funding
was provided, pursuant to the terms of the contract, the Company sent notice of
cancellation effective July 31, 2000.
-3-
<PAGE>
In February 2000, the Company executed a Consulting Agreement with
Global Development Advisors, Inc. ("GDA")); however, shortly thereafter, further
negotiations ensued and the agreement never became effective. Under the
agreement, GDA was to provide business and marketing consulting services, assist
in the implementation of a strategic plan and assist, coordinate and monitor the
Company's investor relations program. The agreement was for a term of six (6)
months and could have been extended by the Company. In lieu of cash payments for
services, GDA agreed to accept 50,000 shares of the Company's Common Stock under
the Company's 2000 Stock Plan approved by its shareholders on February 28, 2000
and options to purchase an additional 50,000 shares at an exercise price of
$1.09. Due to the further negotiations, the issuance was never made. The parties
have canceled this Agreement.
On February 29, 2000, the Company entered into a contract with Steel
Beach Productions, Inc. ("Steel Beach") to design, develop, implement and test
the OASiS Version 3.0 web based application. The contract is for a total of
$160,100 and is to be paid $80,500 in cash and $80,500 in stock options. The
Company paid a deposit of $20,012.50 and the balance is to be paid upon delivery
of the prototype, preliminary product and final product. The options are due at
the time of delivery of the final product. The common stock option number will
be calculated based on the average closing share price ("ACSP") in the twenty
(20) days of trading prior to deliver of the final product. The exercise price
will be 50% of the twenty (20) day average closing price as quoted on the OTC
BB. The number of options issued will be calculated by multiplying $80,050 times
two (2) and dividing by the ACSP. The options are to have a term of five (5)
years and are to conform to Company's consultant option policy as far as
additional terms and details. This agreement with Steel Beach replaces two
earlier agreements; specifically, one agreement for Version 2.0 dated December
30, 1999 in the amount of $37,800 in cash and $37,800 in stock options, and one
agreement for Version 3.0 dated December 30, 1999 in the amount of $42,250 in
cash and $42,250 in stock options. All efforts expended by Steel Beach
Productions under these two earlier contracts are compensated under the terms of
this agreement. The Company retains all propriety rights in the application.
Steel Beach is responsible for its own costs and expenses. The agreement may be
canceled by either party on thirty (30) days written notice. The product was
delivered and the parties are in the process of reconciling amounts owed between
them.
On May 16, 2000, the Company entered into a contract with Horizon
Marketing Group ("Horizon") for the strategic planning, design and development
for sales and marketing presentations by the Company and for the Company's
website. The contract was amended on June 30, 2000. The initial contract was for
$18,300 which was increased in the amendment by $14,405, for a total contract
price of $32,705 of which the Company has thus far paid approximately one-third.
The contract is for a designated schedule of work which is paid under a fee
schedule and by a reward bonus. Under the reward bonus, Horizon will, as the
last payment, receive the greater of 2% of the value of each contract with a
partner secured by virtue of the work performed or $17,705 by December 1, 2000.
Further, Horizon can be engaged to provide ongoing development services at the
rate of $1000 per month. The contract terminates when the project is completed.
On May 25, 2000, the Company entered a staff leasing agreement with
EPIX IV, Inc. ("EPIX") as a replacement for comparable services previously
provided by Staff Leasing. Like the Staff Leasing arrangement, the EPIX
arrangment creates a co-employment relationship between EPIX and the Company
relative to the employees who work at the Company.
-4-
<PAGE>
Effective June 7, 2000, the Company's line of credit with SouthTrust
renewed through August 12, 2000, with an option to extend the maturity until
October 15, 2000 if the Company pledges a certificate of deposit in the amount
of $25,000. The interest rate is prime plus 1.5% and the line is secured by the
Company's equipment, receivables and inventory. The line is guaranteed
personally by Dr. Swor.
Effective July 1, 2000, the Company entered into an agreement with AORN
under which AORN will provide certain of its proprietary content on a
non-exclusive license basis to the Company. Under the agreement, AORN will
deliver to the Company certain of its content for which it grants the Company a
non-exclusive license to market and promote. The Company receives a substantial
credit toward advertising in the AORN Journal and other AORN publications. The
Company is required to provide the software and hardware to promote and market
the AORN content. The Company is required to pay AORN $117,000 as the license
fee and contact hours fee for the first year of the agreement. AORN will
reimburse the Company for certain conversion costs and to pay the cost of web
enabling Home Study Courses sponsored by AORN. The agreement is for a term of
three (3) years and it may be terminated by either party on 180 day notice. If
terminated without cause, the Company is entitled to a refund of any unused
license and user fees. AORN retains ownership of its intellectual property while
the Company retains the ownership of its OASiS intellectual property.
On July 6, 2000, the Company entered into an agreement with Carver
Cross Securities Corp. ("CCSC") for investment banking services, including
financial advisory services and efforts to secure equity or debt financing. TK
has given verbal approval for this arrangement, subject to final approval of any
financing package. The CCSC agreement is exclusive for a term of 120 days
commencing the later of September 6, 2000 or the date a placement memorandum is
ready for distribution. Under the agreement, CCSC receives a retainer of $6,000,
plus a warrant to purchase 40,000 shares of the Company's common stock for a
period of 5 years at an exercise price of $0.625 per share and monthly payments
of $2,5000 plus warrants for 40,000 shares of common stock.. In any case, under
the agreement, CCSC will not receive warrants to purchase more than 120,000
shares. CCSC will receive compensation for equity financing arranged by CCSC,
the sale of assets or a public offering placement. In the case equity financing
is arranged, CCSC will receive complete warrants exercisable for 5 years at an
exercise price equal to 101% of the amount paid by the investors. In addition,
CCSC receives approved expenses.
The Company is negotiating a new contract with US Surgical. It is
intended that this agreement will supercedes all prior agreements between the
parties. Under the terms of the new agreement, it is intended that US Surgical
will pay the Company for all services provided by the Company under the previous
agreements and will pay the Company an additional sum for future services. This
new arrangement is principally due to the ineffective introduction by US
Surgical of OASiS into the healthcare environment through hardware
installations. Both companies realize that the value of OASiS is the content and
product it delivers. This new content agreement, if completed as intended, will
emphasize US Surgical's continued belief in the
-5-
<PAGE>
information exchange network which the Company now had embarked upon as its
focus. Although negotiations have progressed to the stage of where the agreement
has been drafted and signed by US Surgical, to date, the said agreement has not
been executed by the Company as the Board of Directors is in the processing of
reviewing it. There can be no assurance that the agreement as drafted will be
accepted by the Company's Board.
In December 1999, the Company executed a Loan Agreement with Thomson
Kernaghan & Co., Ltd. ("TK"), as Agent and Lender, whereby TK agreed to make
loans to the Company of up to $5,000,000 in installments for a period commencing
with the date of the agreement and ending on November 30, 2002 (the "TK Loan
Commitment"). Under the terms of the TK Loan Commitment, each installment is
supported by a convertible note and security agreement and the Agent and Lender
are granted warrants to purchase shares of the Company's Common Stock. Further,
2,700,000 shares are held by TK in escrow for the potential conversion under the
notes or exercise of the warrants. Under the terms of the TK Loan Agreement, an
initial loan of $650,000 was made on December 30, 1999. On March 31, 2000 the
Company received a second installment under the TK Commitment in the amount of
$650,000. On April 28, 2000, TK elected to convert $100,000 of outstanding
principal and $2,630 of the accrued interest into shares of Common Stock at a
price of $0.5625 per share which represents 182,453 shares. On June 9, 2000, TK
elected to convert $120,000 of outstanding principal and $4,129 of the accrued
interest into shares of Common Stock at a price of $0.375 per share which
represents 331,010 shares. On July 11, 2000, TK elected to convert $40,000 of
outstanding principal and $1,683.13 of the accrued interest into shares of
Common Stock at a price of $0.375 per share which represents 111,155 shares. The
Company granted TK registration rights and was obligated to file a Form S-3
within sixty (60) days of the agreement. The Company filed a registration
statement on Form S-3 on March 2, 2000 covering initially 20,038,097 shares of
its Common Stock. The issuance of the securities was made pursuant to Regulation
S of the Act. The Form S-3 registration statement was declared effective on
April 11, 2000. Since the Company did not meet financial projections which were
an integral part of the transaction, TK and the Company are re-negotiating an
arrangement which it is anticipated will be in the form of an amendment to the
TK Loan Commitment relative to future installments.
The TK Loan Commitment, as draw downs are taken and as interest
accrues, will increase the long term debt of the Company. The Company has
entered into a consulting agreement with CCSC for other potential funding;
however, to date, has not concluded terms for any financing under such
agreements. With the TK Loan Commitment and in the event additional debt is
raised, the Companyn will incur future interest expense. The TK Loan Commitment,
if fully converted and all warrants are exercised will dilute the interest of
existing shareholders and in the event additional equity is raised, management
may be required to dilute the interest of existing shareholders further or
forego a substantial interest in revenues, if any. In the event that the Company
is successful in securing additional debt financing, the amount of such
financing, depending upon its terms, would increase either the short or long
term debt of the Company or both.
Discussion and Analysis
The Company was founded in 1992 to combat the potential spread of
bloodborne pathogenic infections such as HIV and hepatitis. It has broadened its
mission to research, develop, manufacturing, marketing and selling medical
products and services to the healthcare community.
-6-
<PAGE>
The Company was in the development stage until 1993 when it began
commercial shipments of SutureMate(R), its first product. From inception in
June, 1992 through December 31, 1999, the Company generated revenues of
approximately $1,275,000 from a limited number of customers. Since inception
through December 31, 1999, the Company has generated cumulative losses of
approximately $2,780,000. Although the Company has experienced a significant
percentage growth in revenues from fiscal 1992 to fiscal 1999, the Company does
not believe prior growth rates are indicative of future operating results,
especially in light of the contract with AORN and its new Internet-based site,
OASiSOR.com and the anticipated contract with US Surgical. Due to the Company's
operating history and limited resources, among other factors, there can be no
assurance that profitability or significant revenues on a quarterly or annual
basis will occur in the future. Moreover, the Company expects to continue to
incur operating losses through at least the first three quarters of 2000, and
there can be no assurance that losses will not continue after such date. As of
the date hereof the Company has completed installations of fifteen (15) units in
seven (7) hospitals.
As discussed in the independent auditors' report, the operating losses
incurred by the Company raise doubt about its ability to continue as a going
concern. In addition, with the implementation of its agreement with AORN, and if
executed, its new arrangement with US Surgical and/or with the establishment of
one or more strategic alliances in addition to AORN and US Surgical, the Company
expects to experience a period of growth, which requires it to significantly
increase the scale of its operations. This will result in significantly higher
operating expenses. The increase in operating expenses is expected to be
partially funded by an increase in revenues. However, the Company's net loss may
continue to increase. Expansion of the Company's operations may cause a
significant strain on the Company's management, financial and other resources.
The Company's ability to manage recent and any possible future growth, should it
occur, will depend upon a significant expansion of its sales and marketing,
research and development, accounting and other internal management systems and
the implementation and subsequent improvement of a variety of systems,
procedures and controls. There can be no assurance that significant problems in
these areas will not occur. Any failure to expand these areas and implement and
improve such systems, procedures and controls in an efficient manner at a pace
consistent with the Company's business could have a material adverse effect on
the Company's business, financial condition and results of operations. As a
result of such expected expansion and the anticipated increase in its operating
expenses, as well as the difficulty in forecasting revenue levels, the Company
expects to continue to experience significant fluctuations in its revenues,
costs and gross margins, and therefore its results of operations.
The Company's plan of operations for the next twelve months is to focus
on building revenue from development of its website and registered user base.
The Company also is aggressively seeking strategic alliances with targeted
industry partners such as manufacturers of devices, manufacturers of
pharmaceuticals, professional organizations such as nursing associations and
hospital group purchasing organizations and integrated health networks along the
lines created with the AORN contract.
-7-
<PAGE>
The Company estimates that revenues will be sufficient to fund ongoing
operations at the current level when the website is functional and registered
users reach levels of 10,000 or more.
In the short term, to fund operations through the first three quarters
of 2000, the Company will seek to draw upon the funds available under the TK
Commitment, to seek additional funds from strategic alliances with potential
clients, its shareholders, from additional third party financing or seek third
party debt or equity financing other than those planned by the current
anticipated agreements. Currently, the Company has available its existing lines
of credit. The Company has increased its staff from six (6) at fiscal 1999 year
end to eleven (11) as of June 30, 2000. Provided that the TK Commitment and
other funding is available when needed, the Company believes that it can meet
its capital needs through year end. There can be no assurance that the Company
will be successful in these efforts.
As discussed in Note 10 to the Financial Statements, if the financing
referred to above is not secured, the recoverability of the recorded asset
amounts may be impaired.
In 2000, the Company will require between $3 and $5 million in
additional capital in the form of debt or equity to fund the continued expansion
of the Oasis system and its development to meet increased demand and to
implement its plans for increased marketing of its medical device products. This
reduction is due to the new initiative which is less hardward intensive and
requires less maintenance. Under the TK Commitment, $3,700,000 remains available
under the terms of the agreement. The Company has met with several venture
capital firms, investment bankers, factoring companies and traditional lending
sources, each of whom have expressed early interest and many of whom are
awaiting the conclusion of the testing period. Other than the TK Commitment, the
Company has accepted no definite offer from any other source although it has
entered into an agreement with Carver Cross. There can be no assurance that such
long-term financing will be available to the Company or that it will be on terms
that the Company may seek.
Results of Operations for the Thee and Six Months Ended June 30, 2000 and 1999
Overview
From its inception, the Company has incurred losses from operations. As
of June 30, 2000, the Company had cumulative net losses totaling approximately
$3,640,000. During fiscal 1999, management shifted its focus to aggressively
marketing its proprietary products, especially those associated with Oasis
Information Exchange.
Financial Position
As of June 30, 2000, the Company had a deficit of working capital of
$24,276, as compared to a deficit of working capital of $43,229 at June 30,
1999. This decrease in deficit is primarily due to additional borrowings on the
TK Commitment and revenues received from US Surgical.
Revenues
For the six months ended June 30, 2000 and 1999, the Company had total
revenues of $159,725 and $52, 734, respectively. For the six months ended June
30, 2000, revenues were comprised primarily of license and production fees
provided to US Surgical pursuant to the contract dated July 1999. For the three
months ended June 30, 2000 and 1999, the Company generated revenues of $24,069
and $13,157, respectively. The increase of $10,912 is due to the services
performed under the contract with US Surgical. Revenues for the three and six
months ended June 30, 2000 are significatantly less than anticipated due to U.S.
Surgicial's net having met the TOuchPort intallation and licensing requirements
of its contract dated July 1999. Pursuant to such contract US Surgical was to
have licensed Oasis for 200 hospital by July 2000. As of this date, only four
licenses were purchased by U.S. Surgical.
-8-
<PAGE>
Selling, General, and Administrative Expenses
For the six months ended June 30, 2000, operating expenses increased by
$354,406 or 89% from $396,900 for the six months ended June 30, 1999. This
increase is primarily related to marketing support expenditures to sustain the
launch of the Company's Oasis Information Exchange. For the three months ended
June 30, 2000 and 1999, operating expenses increased $157,672 from $257,916 in
1999 to $415,588 in 2000 due to increased personnel and marketing. In accordance
with the Company's marketing plan for fiscal 2000, expenses related to
promotion, trade shows, and conventions were increased to enhance the industry
awareness of the company's products and services.
In the past, the Company has focused on the design and development of
proprietary products. For fiscal 2000, the Company has launched an aggressive
marketing plan that is designed to increase worldwide sales of its products.
Surgical believes that the increased operating expenses incurred during the six
months ended June 30, 2000 will position the Company to generate increased
revenue in the 2000 fiscal year.
Liquidity and Capital Resources
The financial condition, liquidity and capital resources of the Company
should be assessed in context with the ability of the Company to continue as a
going concern as discussed in the independent auditors' report.
The Company's operations have been funded primarily from the $1,300,000
proceeds of draw downs under the TK Commitment completed in the fourth quarter
1999 and from cash flow of approximately $150,000 from licensing and production
fees for Oasis during the six months ended June 30, 2000. This allowed the
Company to enhance its Oasis software and data base and fund current operations.
At June 30, 2000, the Company has a $231,372 cash position.
In addition to the balance of $3,700,000 available under the TK
Commitment, the Company has a line of credit in the amount of $100,000 that
matures on October 15, 2000 and is guaranteed by Dr. Swor. In the past, the line
of credit also has been used to fund operations on a short-term basis and
$100,000 is currently outstanding.
Net cash used for investing for the six months ended June 30, 2000 was
approximately $142,000, representing primarily enhancements to the current
version of Oasis. In the short term, to fund operations through the balance of
fiscal 2000, the Company will be required to make additional draw downs under
the TK Commitment, seek additional funds from strategic alliances with potential
clients, its shareholders, from additional third party financing or seek third
party debt or equity financing other than those planned by the current
agreements. Additionally, the Company anticipates that revenues will begin to be
generated in the third and fourth quarter of 2000 and that such revenues will
help to fund operations. Provided that additional funding is secured, the
Company believes that it can meet its capital needs through year end. There can
be no assurance that the Company will be successful in these efforts.
Forward-Looking Statements
This Form 10-QSB includes "forward-looking statements" within the
meaning of Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of
-9-
<PAGE>
1934, as amended. All statements, other than statements of historical facts,
included or incorporated by reference in this Form 10-QSB which address
activities, events or developments which the Company expects or anticipates will
or may occur in the future, including such things as future capital expenditures
(including the amount and nature thereof), demand for the Company's products and
services, expansion and growth of the Company's business and operations, and
other such matters are forward-looking statements. These statements are based on
certain assumptions and analyses made by the Company in light of its experience
and its perception of historical trends, current conditions and expected future
developments as well as other factors it believes are appropriate in the
circumstances. However, whether actual results or developments will conform with
the Company's expectations and predictions is subject to a number of risks and
uncertainties, general economic market and business conditions; the business
opportunities (or lack thereof) that may be presented to and pursued by the
Company; changes in laws or regulation; and other factors, most of which are
beyond the control of the Company. Consequently, all of the forward-looking
statements made in this Form 10-QSB are qualified by these cautionary statements
and there can be no assurance that the actual results or developments
anticipated by the Company will be realized or, even if substantially realized,
that they will have the expected consequence to or effects on the Company or its
business or operations.
PART II
Item 1. Legal Proceedings.
The Company knows of no legal proceedings to which it is a party or to
which any of its property is the subject, which are pending, threatened or
contemplated or any unsatisfied judgments against the Company.
Item 2. Changes in Securities and Use of Proceeds
At a meeting of the Board of Directors held on June 6, 2000, a resolution was
passed to modify the Company's 2000 Stock Option and Awards Plan by providing of
the 10,000,000 shares authorized under the plan, that in any calendar year,
options and awards to acquire no more than 1,000,000 shares will be granted.
Further, at the same meeting, the Board adopted a resolution
regarding lock-up provisions on holders of existing options and approved a form
of voluntary restriction agreement. Under this arrangement, certain holders of
such options, particularly current and certain prior members of the Board and
current and certain prior officers of the Company, have agreed to specific
lock-up provisions which restrict resale and provide for the placement of a
legend upon their shares acquired under the options granted under the plans in
force in 1994, 1998, and 1999. Voluntary restriction agreements have been
executed by the parties to which it applies.
Item 3. Defaults in Senior Securities
None
Item 4. Submission of Matters to a Vote of Security Holders.
No matters were submitted to the Security Holders for a vote during the
quarter ended June 30, 2000.
-10-
<PAGE>
Item 5. Other Information
None
Item 6. Exhibits and Reports on Form 8-K
(a) The exhibits required to be filed herewith by Item 601 of Regulation
S-B, as described in the following index of exhibits, are incorporated herein by
reference, as follows:
<TABLE>
<S> <C>
Exhibit No. Description
------------- ------------------------------------------------------------------
3.(I).1 Articles of Incorporation of Surgical Safety Products, Inc., a Florida corporation
filed May 15, 1992 [1]
3.(II).1 Bylaws of Sheffeld Acres, Inc., now known as Surgical Safety Products, Inc. [1]
3.(II).2 Amended Bylaws of Surgical Safety Products, Inc. [2]
4.1 * Voluntary Restriction Agreement between the Company and holders of Options
under the 1994, 1998 and 1999 Stock Option Plan
10.1 Acquisition of Endex Systems, Inc. d/b/a/ InterActive PIE dated December 8, 1997
[1]
10.2 Prepaid Capital Lease Agreement with Community Health Corporation relative to
Sarasota Medical Hospital OASiS Installation dated January 30, 1998 [1]
10.3 Letter of Intent with United States Surgical Corporation dated February 12, 1998 [1]
10.4 Form of Rockford Industries, Inc. Rental Agreement and Equipment Schedule to
Master Lease Agreement [1]
10.5 Ad-Vantagenet Letter of Intent dated June 19, 1998 [1]
10.6 Distribution Agreement with Morrison International Inc. dated September 30, 1996
[1]
10.7 Distribution Agreement with Hospital News dated August 1, 1997 [1]
10.8 Clinical Products Testing Agreement with Sarasota Memorial Hospital dated January
30, 1998 [1]
10.9 Real Estate Lease for Executive Offices effective June 1, 1998 [1]
10.10 Employment Agreement with Donald K. Lawrence dated April 1, 1997 [1]
10.11 Employment Agreement with G. Michael Swor dated June 15, 1998 [1]
10.12 Employment Agreement with Frank M. Clark dated June 15, 1998 [1]
10.13 Agreement for Consulting Services with Stockstowatch.com Inc. dated March 30,
1988 [1]
10.14 Form of Employee Option Agreement dated July 1994 [1]
10.15 Form of Employee Option Agreement dated 1998 [1]
</TABLE>
-11-
<PAGE>
<TABLE>
<S> <C>
10.16 Form of Consultants Option Agreement dated July 1994 [1]
10.17 Form of Consultants Option Agreement dated 1998 [1]
10.18 Confidential Private Offering Memorandum dated May 30, 1995 [1]
10.19 Supplement to Private Offering Memorandum dated October 30, 1995 [1]
10.20 Stock Option Agreement with Bay Breeze Enterprises LLC dated April 9, 1998 [1]
10.21 Revolving Loan Agreement, Revolving Note, Security Agreement with SouthTrust
Bank dated May 2, 1997 [1]
10.22 Agreement between the Company and T. T. Communications, Inc. dated October 15,
1998 [2]
10.23 Agreement between the Company and U.S. Surgical Corporation dated October 28,
1998. [2]
10.24 Collaborative Agreement between the Company and Dr. William B. Saye dated
November 16, 1998. [2]
10.25 Kiosk Information System, Inc. Purchase Order dated November 3, 1998 [2]
10.26 Surgical Safety Products 1999 Stock Option Plan adopted January 1999 [2]
10.27 Form of the Employee Option Agreement under the Surgical Safety Products 1999
Stock Option Plan dated January 1999 [2]
10.28 Form of the Director, Consultant and Advisor Option Agreement under the Surgical
Safety Products 1999 Stock Option Plan dated January 1999 [2]
10.29 Verio, Inc. Access Service Agreement dated February 16, 1999. [2]
10.30 Form of Investor Subscription Documents and Agreements relative to the April 1999
Self Directed Private Placement Offering under Rule 506 of Regulation D. [3]
10.31 Form of the Warrant issued pursuant to the April 1999 Self Directed Private
Placement Offering under Rule 506 of Regulation D. [3]
10.32 Consulting Agreement dated April 1999 with Koritz Group, LLC. [3]
10.33 Agreement dated April 1999 with KJS Investment Corporation. [4]
10.34 Agreement dated May 1999 with Ten Peaks Capital Corp. [4]
10.35 Private Partner Network Agreement dated July 30, 1999 with US Surgical [5]
10.36 Staff/Client Leasing Agreement dated October 16, 1999, as amended September 15,
1999 [5]
10.37 Agreement dated July 15, 1999 with Triton Capital Inc.[6]
10.38 Effective December 30, 1999, Loan Agreement, Note, Security Agreement, Lender's
Warrant, Agent's Warrant, Registration Rights Agreement and Escrow Agreement
relative to the December 1999 transaction with Thomson Kernaghan & Co., Inc. and
Amendment thereto. [7]
</TABLE>
-12-
<PAGE>
<TABLE>
<S> <C>
10.39 Effective January 3, 2000 IBM Customer Agreement and Statement of Work. [7]
10.40 Investment Banking Services Agreement dated February 2, 2000 with Dunwoody
Brokerage Services Inc. [8]
10.41 Consulting Agreement dated February 15, 2000 with Global Development Advisors
Inc. [8]
10.42 Surgical Safety Products 2000 Stock Option and Award Plan [8]
10.43 Agreement with Steel Beach Productions dated February 29, 2000 [9].
10.44 * Agreement with Horizon Marketing Group dated May 16, 2000
10.45 * Agreement with EPIX dated May 25, 2000
10.46 * Amendment to the Company's 2000 Stock Option and Awards Plan dated June 6,
2000
10.47 * Revolving Loan Agreement, Revolving Note, Security Agreement with SouthTrust
Bank dated June 7, 2000
10.48 * Agreement with AORN effective July 1, 2000
10.49 * Agreement with Carver Cross dated July 6, 2000
13.1 Definitive Proxy Statement filed February 28, 2000 [8]
27.1 * Financial Data Sheet
</TABLE>
----------------
[1] Previously filed with the Company's Form 10SB
[2] Previously filed with the Company's Amendment No. 1 to the Form 10SB
[3] Previously filed with the Company's Form 10QSB for the Quarter ended March
30, 1999
[4] Previously filed with the Company's Form 10QSB for the Quarter ended June
30, 1999
[5] Previously filed with the Company's Amendment No. 2 to the Form 10SB
[6] Previously filed with the Company's Form 10QSB for the Quarter ended
September 30, 1999
[7] Previously filed with the Company's Form S-3 on March 2, 2000.
[8] Previously filed with the Company's Form 10KSB for the fiscal year ended
December 31, 1999.
[9] Previously filed with the Company's Form 10QSB for the Quarter ended March
31, 2000.
* Filed herewith
(b) No Reports on Form 8-K were filed during the quarter ended March 31,
2000.
-13-
<PAGE>
SIGNATURES
In accordance with Section 12 of the Securities Exchange Act of 1934, the
registrant caused this Registration Statement to be signed on its behalf by the
undersigned, thereunto duly authorized.
Surgical Safety Products, Inc. (Registrant)
Date: August 21, 2000 By:/s/ Pauline J. Parrish
---------------------------------------
Pauline J. Parrish
Chief Financial Officer
-14-
